title: [Influence of diabetes on the clinical course and hospital mortality of patients with recent myocardial infarction].
abstract: In group of 1026 patients with recent myocardial infarction (from program "Streptokinase in acute myocardial infarction"--patients below 70 years old, up to 12 hours from the onset of the symptoms) we analyzed the influence of diabetes on clinical course and hospital mortality. In this group were 77 patients with noninsulin-dependent diabetes (NIDDM), and 21 patients were insulin-dependent diabetes (IDDM). The risk factors of coronary heart disease and myocardial infarction in the past were significantly more often in patients with diabetes than in subjects without diabetes. In hospital mortality was significantly higher (p < 0.05) in group of patients with diabetes (17.3%) than in group without diabetes (9.5%). Reinfarction in the hospital period occurred significantly more often in diabetes group (p < 0.01). Congestive heart failure was observed in 50% patients with diabetes and in 32.3% cases without diabetes (p < 0.01), the left ventricle aneurysm occurred accordingly 9.8% i 5.2% (N.S.). Early ventricular fibrillation and atrio-ventricular blocks occurred with the same frequency in the both groups. We analyzed also the influence of thrombolytic therapy on clinical course in patients with diabetes proving the benefit of this treatment.
authors: Kliniki Kardiologii Instytutu Chorób Wewnetrznych Akademii Medycznej, Warszawie.
authors: J
authors: J
authors: Stanisławska
authors: J
authors: J
authors: Krzymień
authors: G
authors: G
authors: Opolski
authors: T
authors: T
authors: Wardaszko
authors: A
authors: A
authors: Górecki
authors: T
authors: T
authors: Kraska
mesh_terms: D000368:Aged; D003922:Diabetes Mellitus, Type 1 / Q000150:complications*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D017052:Hospital Mortality; D006801:Humans; D009203:Myocardial Infarction / Q000209:etiology / Q000401:mortality*; D012307:Risk Factors; D015996:Survival Rate
vernacular_title: Wpływ cukrzycy na przebieg kliniczny i śmiertelność wewnatrzszpitalna chorych ze świezym zawałem serca.